CD274 and neoplasm: Immune checkpoint inhibitors, especially programmed cell death protein 1 (PD-1), programmed cell death ligand 1 (PD-L1), and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), target the escape mechanisms of tumor cells (24).